Skip to main content
Equibles

AE Wealth Management LLC

Position in DYAI — Dyadic International Inc

CIK 1697723 TOPEKA, KS
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$48,380
+$4,301 QoQ
Shares Held
53,756
0.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 39 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AE Wealth Management LLC holds $11,774,403 across 15 Biotechnology names. DYAI ranks #13 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 24,046 $2,725,848
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,871 $1,922,817
3 EXEL
Exelixis, Inc.
 32,548 $1,770,929
4 RPRX
Royalty Pharma plc
 29,628 $1,661,236
5 JAZZ
Jazz Pharmaceuticals plc
 3,184 $767,232
6 REGN
Regeneron Pharmaceuticals, Inc.
 1,094 $682,131
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 8,050 $656,141
8 CYTK
Cytokinetics Inc
 5,316 $452,857

All Filings in DYAI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,380 53,756
2026-03-31 $44,079 53,756
2025-12-31 $50,530 53,756
2025-09-30 $63,432 53,756
2025-06-30 $53,218 53,756
2025-03-31 $72,570 53,756
2024-12-31 $86,066 49,181
2024-09-30 $19,864 19,100
2024-06-30 $28,268 19,100
2024-03-31 $31,897 19,100
2023-12-31 $25,689 15,956
2023-09-30 $30,635 15,956
2023-06-30 $35,427 18,356